| Title |
Tamoxifen use for the management of mania: a review of current preclinical evidence
|
|---|---|
| Published in |
Psychopharmacology, January 2014
|
| DOI | 10.1007/s00213-013-3397-x |
| Pubmed ID | |
| Authors |
Fernanda Armani, Monica Levy Andersen, José Carlos Fernandes Galduróz |
| Abstract |
Preliminary data on the efficacy of tamoxifen in reducing manic symptoms of bipolar disorder (BD) suggest that this agent may be a potential treatment for the management of this psychiatric disorder. However, the antimanic properties of tamoxifen have not been fully elucidated, hampering the development and/or use of mood-stabilising drugs that may share its same therapeutic mechanisms of action. Notably, we may gain a greater understanding of the neurobiological and therapeutic properties of tamoxifen by using suitable animal models of mania. |
Mendeley readers
The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 27 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 8 | 30% |
| Student > Master | 4 | 15% |
| Student > Ph. D. Student | 4 | 15% |
| Other | 2 | 7% |
| Researcher | 2 | 7% |
| Other | 2 | 7% |
| Unknown | 5 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 7 | 26% |
| Social Sciences | 3 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 11% |
| Agricultural and Biological Sciences | 2 | 7% |
| Chemistry | 2 | 7% |
| Other | 5 | 19% |
| Unknown | 5 | 19% |